En esta página
01TECX precio
02Instantánea
03Gráfico
04Divisiones de acciones
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
26Mis Métricas
TECX Tectonic Therapeutic, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 6, 2026
$22,54
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$14,60mínimo 52 semanas
$39,53máximo 52 semanas
Capitalización Bursátil (MRQ)
$434M
P/E
-5.6
BPA
$-4.05
tus insignias
Rango 52S
$15–$40
Calificación del Analista
BUY
Precio Objetivo
$77
P/E
-5.6
ROE
-27.7%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
TECX Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$22.54
Capitalización Bursátil (MRQ)
$434M
P/E
-5.6
BPA
$-4.05
ROE
-27.7%
Rango 52S
$15–$40
TECX Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Divisiones de acciones
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 21 de junio de 2024 | 1-for-12 | Inversa |
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
BPA$-4.052021-12-31 → 2025-12-31
Flujo de caja libre$-60M2018-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | TECX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -5.6promedio 5A ≈-6.5 | ≈-6.5 | · | · | |
| P/C (MRQ) | 1.9promedio 5A ≈6.1 | ≈6.1 | 3.0 | Valor razonable | |
| Precio / FCF (TTM) | -6.0promedio 5A ≈-10.5 | ≈-10.5 | · | · | |
| Precio / Flujo de Caja (TTM) | -6.0promedio 5A ≈-10.6 | ≈-10.6 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 1.7promedio 5A ≈5.9 | ≈5.9 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | TECX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA | -35.8%promedio 5A ≈-40.6% | ≈-40.6% | -42.2% | De primer nivel | |
| ROE | -27.7%promedio 5A ≈-18.5% | ≈-18.5% | -78.7% | De primer nivel | |
| ROIC | -34.0% | · | -67.4% | De primer nivel |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | TECX | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 22.3promedio 5A ≈14.6 | ≈14.6 | 5.1 | Liquidez sólida | |
| Quick Ratio (Ratio Rápido) | 26.3promedio 5A ≈14.1 | ≈14.1 | 2.9 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
4.4%
Próximo informe
Nov 04, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 19, 2026 | $-1.18 | $-1.38 | 14.6% |
| 31 de marzo de 2026 | $-1.34 | $-1.21 | -11.1% | |
| 31 de diciembre de 2025 | $-1.03 | $-1.13 | 8.5% | |
| 30 de septiembre de 2025 | $-1.02 | $-1.07 | 4.5% | |
| 30 de junio de 2025 | $-1.07 | $-1.00 | -6.9% | |
| 31 de marzo de 2025 | $-0.93 | $-1.11 | 16.5% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $63M | $41M | $37M | $72M | $83M | $87M | $55M | $35M | $15M | |
| SG&A Expense | $21M | $17M | $8M | $33M | $36M | $33M | $21M | $11M | $3M | |
| Operating Expenses | $84M | $58M | $45M | $105M | $119M | $120M | $76M | $46M | $18M | |
| Operating Income | $-84M | $-58M | $-45M | $-105M | $-119M | $-120M | $-76M | $-46M | $-18M | |
| Interest Income | $11M | $4M | $581.0K | · | · | $719.0K | $3M | $2M | $57.0K | |
| Other Non-op | $-119.0K | $-511.0K | $396.0K | $-456.0K | $-285.0K | $516.0K | $3M | $-118.0K | $-262.0K | |
| Pretax Income | $-73M | $-58M | · | · | · | · | · | · | · | |
| Income Tax | $1M | $0 | $0 | $0 | · | · | · | · | · | |
| Net Income | $-74M | $-58M | $-43M | $-106M | $-119M | $-120M | $-73M | $-46M | $-19M | |
| EPS (Basic) | $-4.05 | $-6.83 | $-33.76 | $-2.42 | $-2.78 | · | · | · | · | |
| EPS (Diluted) | $-4.05 | $-6.83 | $-33.76 | $-2.42 | $-2.78 | · | · | · | · | |
| Shares (Basic) | 18,322,533 | 8,490,171 | 1,268,512 | 43,739,000 | 42,854 | · | · | · | · | |
| Shares (Diluted) | 18,322,533 | 8,490,171 | 1,268,512 | 43,739,000 | 42,854 | · | · | · | · | |
| EBITDA | $-83M | $-56M | $11M | $-104M | $-117M | $-119M | $-75M | $-46M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $254M | $141M | $29M | $93M | $190M | $260M | $187M | $126M | $6M | |
| Prepaid Expense | $3M | $6M | $2M | $7M | $10M | $8M | $9M | $4M | $345.0K | |
| Other Current Assets | · | · | $570.0K | $1M | $2M | $271.0K | $344.0K | $795.0K | $60.0K | |
| Current Assets | $257M | $147M | $31M | $100M | $199M | $267M | $196M | $130M | $6M | |
| PP&E (Net) | $1M | $2M | $3M | $3M | $4M | $3M | $4M | $3M | $349.0K | |
| PP&E (Gross) | $5M | $5M | $5M | $7M | $8M | $5M | $5M | $3M | $394.0K | |
| Accum. Depreciation | $3M | $3M | $2M | $4M | $4M | $2M | $1M | $384.0K | $45.0K | |
| Other Non-current Assets | $640.0K | $156.0K | $31.0K | $40.0K | $74.0K | $436.0K | $625.0K | $825.0K | $365.0K | |
| Total Assets | $261M | $153M | $39M | $104M | $204M | $271M | $201M | $133M | $7M | |
| Accounts Payable | $1M | $976.0K | $409.0K | $384.0K | $3M | $3M | $4M | $3M | $527.0K | |
| Accrued Liabilities | $7M | $8M | $8M | $12M | $16M | $14M | $10M | $8M | $2M | |
| Current Liabilities | $10M | $12M | $41M | $13M | $19M | $17M | $14M | $11M | $3M | |
| Capital Leases | $0 | $132.0K | $2M | $188.0K | $0 | · | · | · | · | |
| Deferred Tax | · | · | $0 | $0 | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | $500.0K | |
| Total Liabilities | $10M | $12M | $43M | $29M | $34M | $17M | $15M | $11M | $4M | |
| Long-term Debt | · | · | · | $15M | $15M | · | · | · | · | |
| Common Stock | $2.0K | $2.0K | $0 | $4.0K | $4.0K | $4.0K | $3.0K | $2.0K | · | |
| Paid-in Capital | $474M | $289M | $6M | · | · | · | · | · | · | |
| Retained Earnings | $-223M | $-149M | $-91M | $-489M | $-384M | $-264M | $-145M | $-72M | $-23M | |
| AOCI | $-96.0K | $9.0K | $-11.0K | · | · | · | · | · | · | |
| Stockholders' Equity | $251M | $141M | $-85M | $-46M | $169M | $254M | $186M | $122M | $-23M | |
| Liabilities + Equity | $261M | $153M | $39M | $104M | $204M | $271M | $201M | $133M | $7M | |
| Shares Outstanding | 18,738,249 | 14,856,309 | 1,407,753 | 43,916,000 | 43,652,000 | 43,652,000 | 31,643,000 | 23,806,628 | 2,305,173 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $2M | $1M | $1M | $1M | $1M | $850.0K | $380.0K | $45.0K | |
| Stock-based Comp | $10M | $3M | $1M | $12M | $19M | $16M | $7M | $2M | $177.0K | |
| Deferred Tax | $19M | $17M | $15M | $0 | $0 | $0 | $0 | $0 | $0 | |
| Restructuring | · | · | $5M | · | · | · | · | · | · | |
| Other Non-cash | $-16M | $-23M | $-83M | $-4M | $1M | $4M | $-2M | $6M | · | |
| Operating Cash Flow | $-60M | $-59M | $-41M | $-97M | $-98M | $-99M | $-68M | $-38M | $-16M | |
| CapEx | $208.0K | $156.0K | $279.0K | $267.0K | $2M | $1M | $2M | $2M | $383.0K | |
| Investing Cash Flow | $-138.0K | $-156.0K | $-279.0K | $-267.0K | $-2M | $-1M | $-2M | $-2M | $-383.0K | |
| Debt Issued | · | · | · | $0 | $15M | · | · | · | · | |
| Net Debt Issued | · | · | · | $0 | $15M | · | · | · | · | |
| Stock Issued | · | · | $86.0K | $204.0K | · | · | $129M | $104M | · | |
| Net Stock Activity | · | · | $86.0K | · | · | · | $129M | · | · | |
| Financing Cash Flow | $173M | $172M | $34M | $262.0K | $30M | $173M | $130M | $160M | $17M | |
| Net Change in Cash | $113M | $112M | $-7M | $-97M | $-70M | $73M | $61M | $121M | $606.0K | |
| Taxes Paid | $1M | $0 | · | · | · | · | · | · | · | |
| Free Cash Flow | $-60M | $-59M | $-63M | $-97M | $-100M | $-100M | $-69M | $-39M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -35.8% | -60.3% | 11.9% | -68.8% | -50.1% | -50.7% | -43.7% | -66.0% | · | |
| ROE | -27.7% | -39.8% | 162.5% | -122.1% | -65.6% | -51.8% | -37.1% | -35.8% | · | |
| ROIC | -34.0% | · | · | · | · | · | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 26.6 | 12.6 | 15.8 | 7.6 | 10.3 | 16.1 | 14.0 | 12.3 | · | |
| Quick Ratio | 26.3 | 12.2 | 15.4 | 7.1 | 9.8 | 15.6 | 13.3 | 11.9 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $13.41 | $9.48 | $2.12 | $1.72 | $4.08 | $6.12 | $5.88 | $5.13 | · | |
| Cash Flow / Share | $-3.28 | $-6.96 | $-1.42 | $-2222.46 | · | · | · | · | · | |
| Cash / Share | $13.54 | $9.51 | $2.20 | $2.11 | $4.56 | $6.25 | $5.91 | $5.31 | · | |
| Dividend / Share | $0.00 | $0.00 | · | · | · | · | · | · | · | |
| EPS (TTM) | $-4.05 | $-6.83 | $-33.76 | $-2.42 | $-2.78 | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-74M | $-58M | $-43M | $-106M | $-119M | $-120M | $-73M | $-46M | · | |
| Market Cap | $391M | $686M | $729M | $374M | $1.92B | $6.95B | $7.64B | $4.76B | · | |
| P/E | -5.2 | -6.8 | -0.5 | -3.5 | -16.6 | · | · | · | · | |
| P/B | 1.6 | 4.9 | 7.7 | 5.0 | 11.3 | 27.3 | 41.1 | 38.9 | · | |
| P / Tangible Book | 1.6 | 4.9 | · | · | 11.3 | 27.3 | · | · | · | |
| P / Cash Flow | -6.5 | -11.6 | -11.5 | -3.8 | -19.6 | -70.4 | -113.0 | -126.3 | · | |
| P / FCF | -6.5 | -11.6 | -11.5 | -3.8 | -19.1 | -69.6 | -110.4 | -120.5 | · | |
| Earnings Yield | -19.4% | -14.8% | -206.9% | -28.4% | -6.0% | · | · | · | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $18M | $21M | $16M | $17M | $17M | $13M | $9M | $14M | $7M | $11M | $3M | $8M | $9M | $17M | $18M | $16M | |
| SG&A Expense | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $2M | $-11M | $6M | $5M | $8M | $7M | $7M | |
| Operating Expenses | $24M | $27M | $22M | $22M | $22M | $18M | $14M | $20M | $11M | $13M | $-1M | $10M | $11M | $25M | $25M | $23M | |
| Operating Income | $-24M | $-27M | $-22M | $-22M | $-22M | $-18M | $-14M | $-20M | $-11M | $-13M | $1M | $-10M | $-11M | $-25M | $-25M | $-23M | |
| Interest Income | $2M | $2M | $3M | $3M | $3M | $2M | $2M | $2M | $318.0K | $256.0K | $133.0K | $97.0K | $224.0K | · | · | · | |
| Other Non-op | $-5.0K | $-113.0K | $-8.0K | $-31.0K | $-48.0K | $-32.0K | $-96.0K | $-7.0K | $-5.0K | $-403.0K | $390.0K | $-1.0K | $-8.0K | $15.0K | $-321.0K | $-95.0K | |
| Pretax Income | $-22M | · | $-19M | $-19M | $-19M | · | $-12M | $-18M | $-13M | · | · | · | · | · | · | · | |
| Income Tax | $77.0K | · | $254.0K | $0 | $976.0K | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | · | · | |
| Net Income | $-22M | $-25M | $-19M | $-19M | $-20M | $-16M | $-12M | $-18M | $-13M | $-15M | $-8M | $-10M | $-10M | $-14M | $-25M | $-23M | |
| EPS (Basic) | $-1.18 | $-1.34 | $-1.03 | $-1.02 | $-1.07 | $-0.93 | $9.68 | $-1.20 | $-4.34 | $-10.97 | $-17.06 | $-7.62 | $-8.51 | $-0.57 | $-0.58 | $-0.52 | |
| EPS (Diluted) | $-1.18 | $-1.34 | $-1.03 | $-1.02 | $-1.07 | $-0.93 | $9.68 | $-1.20 | $-4.34 | $-10.97 | $-17.06 | $-7.62 | $-8.51 | $-0.57 | $-0.58 | $-0.52 | |
| Shares (Basic) | 18,964,008 | 18,769,004 | · | 18,712,767 | 18,680,042 | 17,157,661 | · | 14,729,018 | 2,919,872 | 1,387,303 | · | 1,319,147 | 1,228,778 | 44,037,000 | · | 43,773,000 | |
| Shares (Diluted) | 18,964,008 | 18,769,004 | · | 18,712,767 | 18,680,042 | 17,157,661 | · | 14,729,018 | 2,919,872 | 1,387,303 | · | 1,319,147 | 1,228,778 | 44,037,000 | · | 43,773,000 | |
| EBITDA | $-24M | $-27M | · | $-22M | $-22M | $-18M | · | $-20M | $-11M | $-8M | · | $-23M | $68M | $-25M | · | $-23M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $227M | $237M | $254M | $268M | $287M | $306M | $141M | $159M | $185M | $90M | $29M | $106M | $125M | $72M | $93M | $116M | |
| Prepaid Expense | $4M | $3M | $3M | $4M | $3M | $3M | $6M | $4M | $2M | $1M | $2M | $3M | $4M | $5M | $7M | $10M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | $626.0K | · | $805.0K | $792.0K | $845.0K | $1M | $765.0K | |
| Current Assets | $231M | $240M | $257M | $273M | $291M | $310M | $147M | $163M | $187M | $92M | $31M | $109M | $129M | $77M | $100M | $126M | |
| PP&E (Net) | $858.0K | $1M | $1M | $1M | $2M | $2M | $2M | $3M | $3M | · | $3M | $0 | $2M | $3M | $3M | $3M | |
| PP&E (Gross) | · | · | $5M | $5M | $5M | $5M | $5M | $5M | $5M | · | $5M | $7M | $7M | $7M | $7M | $7M | |
| Accum. Depreciation | · | · | $3M | $3M | $3M | $3M | $3M | $3M | $2M | · | $2M | $4M | $4M | $4M | $4M | $3M | |
| Other Non-current Assets | $626.0K | $663.0K | $640.0K | $597.0K | $287.0K | $138.0K | $156.0K | $190.0K | $13.0K | · | $31.0K | $40.0K | $40.0K | $40.0K | $40.0K | $41.0K | |
| Total Assets | $237M | $247M | $261M | $277M | $295M | $315M | $153M | $169M | $194M | $92M | $39M | $111M | $134M | $83M | $104M | $129M | |
| Accounts Payable | $2M | $3M | $1M | $1M | $3M | $6M | $976.0K | $3M | $4M | $243.0K | $409.0K | $910.0K | $1M | $591.0K | $384.0K | $2M | |
| Accrued Liabilities | $7M | $9M | $7M | $7M | $7M | $5M | $8M | $13M | $20M | $3M | $8M | $5M | $8M | $11M | $12M | $14M | |
| Current Liabilities | $10M | $13M | $10M | $9M | $11M | $14M | $12M | $17M | $26M | $4M | $41M | $8M | $12M | $14M | $13M | $16M | |
| Capital Leases | $3M | $3M | $0 | $0 | $0 | $0 | $132.0K | $523.0K | $905.0K | · | $2M | $105.0K | $134.0K | $352.0K | $188.0K | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Total Liabilities | $13M | $16M | $10M | $9M | $12M | $14M | $12M | $18M | $28M | $4M | $43M | $8M | $12M | $30M | $29M | $31M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $15M | · | $15M | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $4.0K | $0 | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Paid-in Capital | $494M | $478M | $474M | $471M | $468M | $466M | $289M | $287M | $285M | · | $6M | · | · | · | · | · | |
| Retained Earnings | $-270M | $-248M | $-223M | $-204M | $-184M | $-164M | $-149M | $-136M | $-118M | $-484M | $-91M | $-468M | $-447M | $-514M | $-489M | $-464M | |
| AOCI | $0 | $0 | $-96.0K | $-75.0K | $-49.0K | $2.0K | $9.0K | $-77.0K | $-61.0K | · | $-11.0K | · | · | · | · | · | |
| Stockholders' Equity | $224M | $230M | $251M | $268M | $284M | $301M | $141M | $150M | $166M | $89M | $-85M | $103M | $122M | $53M | $75M | $98M | |
| Liabilities + Equity | $237M | $247M | $261M | $277M | $295M | $315M | $153M | $169M | $194M | $92M | $39M | $111M | $134M | $83M | $104M | $129M | |
| Shares Outstanding | 19,235,221 | 18,830,436 | 18,738,249 | 18,713,223 | 18,712,138 | 18,671,229 | 14,856,309 | 14,744,477 | 14,734,323 | 44,882,000 | 1,407,753 | 44,558,000 | 44,308,000 | 44,088,000 | 43,916,000 | 43,773,000 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $285.0K | $304.0K | $333.0K | $342.0K | $340.0K | $360.0K | $508.0K | $424.0K | $713.0K | $377.0K | $373.0K | $488.0K | $289.0K | $328.0K | $351.0K | $336.0K | |
| Stock-based Comp | $4M | $3M | $3M | $3M | $3M | $2M | $1M | $2M | $-154.0K | $321.0K | $294.0K | $-3M | $-2M | $3M | $2M | $3M | |
| Restructuring | · | · | · | · | · | · | · | · | · | $5M | · | · | · | · | · | · | |
| Other Non-cash | · | $3M | · | · | · | $360.0K | · | · | · | $-2M | · | · | · | $2M | · | · | |
| Operating Cash Flow | $-21M | $-18M | $-14M | $-18M | $-15M | $-13M | $-17M | $-20M | $-15M | $-9M | $-12M | $6M | $-259.0K | $-20M | $-24M | $-16M | |
| CapEx | $79.0K | $19.0K | $0 | $181.0K | $0 | $27.0K | $3.0K | $153.0K | $0 | $4.0K | $50.0K | $221.0K | $214.0K | $8.0K | $0 | $86.0K | |
| Investing Cash Flow | $-59.0K | $-19.0K | $0 | $-166.0K | $55.0K | $-27.0K | $-3.0K | $-153.0K | $0 | $-4.0K | $-50.0K | $-84M | $-214.0K | $-8.0K | $0 | $-86.0K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | $4.0K | · | $73.0K | $0 | $13.0K | $1.0K | $203.0K | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $4.0K | · | · | · | · | · | · | |
| Financing Cash Flow | $12M | $847.0K | $-141.0K | $-457.0K | $-4M | $178M | $-1M | $-6M | $179M | $-668.0K | $34M | $16M | $-324.0K | $55.0K | $59.0K | $60.0K | |
| Net Change in Cash | $-10M | $-17M | $-15M | $-18M | $-19M | $165M | $-18M | $-26M | $164M | $-10M | $22M | $-62M | $-797.0K | $-20M | $-24M | $-16M | |
| Free Cash Flow | · | $-18M | · | · | · | $-13M | · | · | · | $-8M | · | · | · | $-20M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -8.4% | -9.0% | · | -8.5% | -8.2% | -7.8% | · | -12.7% | -7.7% | -7.8% | · | -18.0% | 48.2% | -19.3% | · | -13.3% | |
| ROE | -8.8% | -9.5% | · | -9.1% | -8.9% | -8.2% | · | -14.0% | -8.8% | -9.6% | · | -21.5% | 56.1% | -25.4% | · | -15.8% | |
| ROIC | -10.9% | · | · | -8.2% | -8.3% | · | · | · | · | · | · | · | · | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 22.3 | 18.5 | · | 29.2 | 25.6 | 22.9 | · | 9.4 | 7.2 | 26.2 | · | 14.4 | 11.0 | 5.4 | · | 7.8 | |
| Quick Ratio | 21.9 | 18.3 | · | 28.6 | 25.3 | 22.7 | · | 9.2 | 7.1 | 25.8 | · | 14.0 | 10.7 | 5.1 | · | 7.2 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $11.64 | $12.24 | · | $14.30 | $15.16 | $16.12 | · | $10.20 | $11.29 | $1.98 | · | $2.31 | $2.75 | $1.20 | · | $2.24 | |
| Cash Flow / Share | · | $-0.98 | · | · | · | $-0.76 | · | · | · | $-0.17 | · | · | · | $-460.61 | · | · | |
| Cash / Share | $11.80 | $12.58 | · | $14.34 | $15.36 | $16.40 | · | $10.79 | $12.56 | $2.02 | · | $2.38 | $2.81 | $1.64 | · | $2.65 | |
| Dividend / Share | · | · | $0.00 | $0.00 | $0.00 | $0.00 | · | $0.00 | · | · | · | · | · | · | · | · | |
| EPS (TTM) | $-4.57 | $-4.46 | · | $6.66 | $6.48 | $3.21 | · | $-33.57 | $-39.99 | $-44.16 | · | $-17.28 | $-10.18 | $-2.31 | · | $-2.49 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-86M | $-83M | · | $-67M | $-66M | $-59M | · | $-53M | $-46M | $-44M | · | $-60M | $-73M | $-91M | · | $-109M | |
| Market Cap | $661M | $582M | · | $294M | $372M | $331M | · | $447M | $243M | $689M | · | $823M | $505M | $529M | · | $336M | |
| P/E | -7.5 | -6.9 | · | 2.4 | 3.1 | 5.5 | · | -0.9 | -0.4 | -0.3 | · | -1.1 | -1.1 | -5.2 | · | -3.1 | |
| P/B | 3.0 | 2.5 | · | 1.1 | 1.3 | 1.1 | · | 3.0 | 1.5 | 7.8 | · | 8.0 | 4.1 | 10.0 | · | 3.4 | |
| P / Tangible Book | 3.0 | 2.5 | · | 1.1 | 1.3 | 1.1 | · | 3.0 | 1.5 | 7.8 | · | 8.0 | 4.1 | 10.0 | · | 3.4 | |
| P / Cash Flow | · | -31.6 | · | · | · | -25.3 | · | · | · | -91.1 | · | · | · | -26.1 | · | · | |
| Earnings Yield | -13.3% | -14.4% | · | 42.4% | 32.6% | 18.1% | · | -110.8% | -242.8% | -287.5% | · | -93.5% | -89.3% | -19.2% | · | -32.4% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Beneficio neto | $-74M | $-58M | $-43M | $-106M | $-119M |
| EPS Diluido | $-4.05 | $-6.83 | $-33.76 | $-2.42 | $-2.78 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 26.6 | 12.6 | 15.8 | 7.6 | 10.3 |
| Ratio Rápido | 26.3 | 12.2 | 15.4 | 7.1 | 9.8 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-60M | $-59M | $-63M | $-97M | $-100M |
Propietarios institucionales (13F) 132 declarantes · $487.9M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
132
Valor en tenencia
$487.9M
Nuevas posiciones
26
Posiciones cerradas
10
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 26 (-3 vs trimestre anterior) | 10 (-8 vs trimestre anterior) | 39 (+3 vs trimestre anterior) | 41 (+4 vs trimestre anterior) | +85K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| FMR LLC | $97 294 233 | 2 830 378 | 19,94% | Acciones |
| TCG Crossover Management, LLC | $41 418 128 | 1 204 891 | 8,49% | Acciones |
| Aberdeen Group plc | $39 250 200 | 1 141 824 | 8,04% | Acciones |
| BlackRock, Inc. | $29 651 600 | 862 592 | 6,08% | Acciones |
| First Light Asset Management, LLC | $27 524 958 | 800 726 | 5,64% | Acciones |
| BAKER BROS. ADVISORS LP | $20 892 713 | 607 788 | 4,28% | Acciones |
| 5AM Venture Management, LLC | $20 853 938 | 606 660 | 4,27% | Acciones |
| BRAIDWELL LP | $20 518 438 | 596 900 | 4,21% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $16 802 672 | 488 805 | 3,44% | Acciones |
| Vestal Point Capital, LP | $14 609 375 | 425 000 | 2,99% | Acciones |
| VANGUARD GROUP INC | $12 513 872 | 599 898 | 2,56% | Acciones |
| KENNEDY CAPITAL MANAGEMENT LLC | $9 700 694 | 282 202 | 1,99% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $9 299 108 | 270 461 | 1,91% | Acciones |
| ORBIMED ADVISORS LLC | $7 789 375 | 226 600 | 1,60% | Acciones |
| STATE STREET CORP | $7 559 338 | 219 908 | 1,55% | Acciones |
| Ikarian Capital, LLC | $7 075 647 | 205 837 | 1,45% | Acciones |
| D. E. Shaw & Co., Inc. | $6 412 656 | 186 550 | 1,31% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6 054 318 | 176 100 | 1,24% | Opción de compra |
| MARSHALL WACE, LLP | $5 916 833 | 172 101 | 1,21% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $5 689 922 | 165 525 | 1,17% | Acciones |
| Squarepoint Ops LLC | $4 985 338 | 145 028 | 1,02% | Acciones |
| AMERIPRISE FINANCIAL INC | $4 896 673 | 142 448 | 1,00% | Acciones |
| WELLS FARGO & COMPANY/MN | $4 036 588 | 117 428 | 0,83% | Acciones |
| NORTHERN TRUST CORP | $3 915 450 | 113 904 | 0,80% | Acciones |
| Soleus Capital Management, L.P. | $3 495 388 | 101 684 | 0,72% | Acciones |
| Woodline Partners LP | $3 437 500 | 100 000 | 0,70% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $3 245 481 | 94 414 | 0,67% | Acciones |
| CITADEL ADVISORS LLC | $3 107 260 | 90 393 | 0,64% | Acciones |
| GOLDMAN SACHS GROUP INC | $2 541 138 | 73 924 | 0,52% | Acciones |
| RAYMOND JAMES FINANCIAL INC | $2 498 169 | 72 674 | 0,51% | Acciones |
| SECTORAL ASSET MANAGEMENT INC | $2 440 934 | 71 009 | 0,50% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $2 351 044 | 68 394 | 0,48% | Acciones |
| JANE STREET GROUP, LLC | $2 262 596 | 65 821 | 0,46% | Acciones |
| MORGAN STANLEY | $2 247 205 | 65 373 | 0,46% | Acciones |
| Connor, Clark & Lunn Investment Management Ltd. | $2 232 313 | 64 940 | 0,46% | Acciones |
| BOOTHBAY FUND MANAGEMENT, LLC | $2 089 003 | 60 771 | 0,43% | Acciones |
| JPMORGAN CHASE & CO | $1 831 995 | 55 364 | 0,38% | Acciones |
| KOTLER KEVIN | $1 668 800 | 80 000 | 0,34% | Acciones |
| Tetragon Partners GP Ltd | $1 598 988 | 46 516 | 0,33% | Acciones |
| PFM Health Sciences, LP | $1 568 566 | 45 631 | 0,32% | Acciones |
| Jump Financial, LLC | $1 491 875 | 43 400 | 0,31% | Acciones |
| Prosight Management, LP | $1 365 753 | 39 731 | 0,28% | Acciones |
| Trexquant Investment LP | $1 271 566 | 36 991 | 0,26% | Acciones |
| Aldebaran Capital, LLC | $1 264 897 | 36 797 | 0,26% | Acciones |
| ExodusPoint Capital Management, LP | $1 211 341 | 35 239 | 0,25% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $1 080 475 | 31 432 | 0,22% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1 046 306 | 30 438 | 0,21% | Acciones |
| MONIMUS CAPITAL MANAGEMENT, LP | $967 416 | 28 143 | 0,20% | Acciones |
| Bank of New York Mellon Corp | $867 872 | 25 247 | 0,18% | Acciones |
| ALPS ADVISORS INC | $658 178 | 19 147 | 0,13% | Acciones |
Activistas y propietarios del %+ 5 6 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Timothy A. Springer, TAS Partners LLC, Chafen Lu ×5 presentaciones | 7 de abril de 2025 | 31,50% | Enmienda | · | SEC |
| Terrance McGuire, Polaris Partners IX, L.P., Polaris Partners GP IX, L.L.C., Polaris Founders Capital Fund I, L.P., Polaris Founders Capital Fund Management Co. I, L.L.C., Polaris Founders Capital Fund II, L.P., Polaris Founders Capital Fund Management Co. II, L.L.C., Jonathan Flint ×3 presentaciones | 7 de abril de 2025 | 6,30% | Enmienda | · | SEC |
| Vida Ventures II, LLC, Vida Ventures II-A, LLC, VV Manager II, LLC ×3 presentaciones | 7 de abril de 2025 | 0,00% | Enmienda | · | SEC |
| ATLAS VENTURE FUND X, L.P., ATLAS VENTURE ASSOCIATES X, L.P., Atlas Venture Associates X, LLC, Atlas Venture Opportunity Fund I, L.P., Atlas Venture Associates Opportunity I, L.P., Atlas Venture Associates Opportunity I, LLC ×2 presentaciones | 28 de octubre de 2024 | · | Presentación inicial | · | SEC |
| SVLSF VI, LLC, SV Life Sciences Fund VI, L.P., SV Life Sciences Fund VI Strategic Partners, L.P., SV Life Sciences Fund VI (GP), L.P. ×2 presentaciones | 16 de febrero de 2021 | · | Presentación inicial | · | SEC |
| Clarus Lifesciences III, L.P., Clarus Ventures III GP, L.P., Blackstone Clarus III L.L.C., Blackstone Holdings II L.P., Blackstone Holdings I/II GP L.L.C., The Blackstone Group Inc., Blackstone Group Management L.L.C., Stephen A. Schwarzman ×4 presentaciones | 6 de agosto de 2019 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 33 insiders · 17 directivos · 15 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Alise Reicin | Chief Executive Officer | 25 de septiembre de 2026 F | 309 078 | 2 | 0 | $105 500 |
| Erik Ostrowski | Interim CEO, President and CFO | 1 de febrero de 2024 M | 29 285 | 0 | 0 | $0 |
| Geoffrey Mackay | President & CEO | 8 de febrero de 2023 A | 188 012 | 0 | 0 | $0 |
| Daniel Lochner | Chief Financial Officer | 25 de septiembre de 2026 F | 58 024 | 1 | 0 | $129 660 |
| Katina Dorton | Chief Financial Officer | 8 de octubre de 2018 M | 10 000 | 0 | 0 | $0 |
| Birgitte Volck | President of R&D | 4 de marzo de 2020 A | · | 0 | 0 | $0 |
| Christian Cortis | Chief Operating Officer | 20 de junio de 2024 A | 126 368 | 0 | 0 | $0 |
| Peter Mcnamara | Chief Scientific Officer | 30 de septiembre de 2026 S | 54 305 | 0 | 8 | $-288 006 |
| Marcella K. Ruddy | Chief Medical Officer | 25 de septiembre de 2026 F | 67 157 | 0 | 3 | $-363 000 |
| Marc Schwabish | Chief Business Officer | 25 de septiembre de 2026 F | 44 903 | 0 | 0 | $0 |
| Azadeh Golipour | Chief Technology Officer | 1 de febrero de 2024 M | 55 872 | 0 | 0 | $0 |
| Essra Ridha | Chief Medical Officer | 1 de febrero de 2024 M | 15 881 | 0 | 0 | $0 |
| Steven Avruch | Chief Legal Officer | 1 de febrero de 2024 M | 22 022 | 0 | 0 | $0 |
| Deanna M Petersen | Chief Business Officer | 8 de febrero de 2023 A | · | 0 | 0 | $0 |
| Christopher Mason | Chief Scientific Officer | 10 de junio de 2021 A | · | 0 | 0 | $0 |
| Diana Escolar | Chief Medical Officer | 10 de junio de 2021 A | · | 0 | 0 | $0 |
| Nerissa Kreher | Chief Medical Officer | 8 de octubre de 2018 M | 2 942 | 0 | 0 | $0 |
| Stefan Vitorovic | Consejero | 9 de junio de 2026 A | 27 774 | 0 | 0 | $0 |
| Praveen P. Tipirneni | Consejero | 9 de junio de 2026 A | 3 037 | 0 | 0 | $0 |
| Phillip B. Donenberg | Consejero | 9 de junio de 2026 A | 2 000 | 0 | 0 | $0 |
| Timothy A. Springer | Consejero | 9 de junio de 2026 A | 1 503 358 | 0 | 0 | $0 |
| Jessica Caroline Chutter | Consejero | 8 de junio de 2026 A | · | 0 | 0 | $0 |
| Terrance McGuire | Consejero | 9 de junio de 2025 A | 573 062 | 0 | 0 | $0 |
| Christopher Paige | Consejero | 6 de junio de 2023 A | 252 512 | 0 | 0 | $0 |
| Annalisa Jenkins | Consejero | 6 de junio de 2023 A | · | 0 | 0 | $0 |
| Philip J. Vickers | Consejero | 6 de junio de 2023 A | 4 800 | 0 | 0 | $0 |
| Gail M Farfel | Consejero | 6 de junio de 2023 A | · | 0 | 0 | $0 |
| Bruce Booth | Consejero | 6 de junio de 2023 A | 5 567 289 | 0 | 0 | $0 |
| Ian T Clark | Consejero | 6 de junio de 2023 A | · | 0 | 0 | $0 |
| Scott Requadt | Consejero | 25 de junio de 2018 C | 2 962 325 | 0 | 0 | $0 |
| ATLAS VENTURE ASSOCIATES X, L.P. | Propietario del 10% | 13 de febrero de 2020 J | 3 710 052 | 0 | 0 | $0 |
| Francois Nader | · | 1 de abril de 2026 A | · | 0 | 0 | $0 |
| Leonard Braden Michael | · | 20 de junio de 2024 J | 33 333 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 20 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,62% | 10 265 NS | 31 de julio de 2026 | N-PORT |
| IWC · iShares Trust | 0,07% | 34 693 SH | 11 de septiembre de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,03% | 1 339 SH | 2 de octubre de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 7 356 SH | 19 de agosto de 2026 | Diario |
| IBB · iShares Trust | 0,02% | 70 963 SH | 11 de septiembre de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 58 897 SH | 19 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,01% | 264 002 SH | 11 de septiembre de 2026 | Diario |
| RSSL · Global X Funds | 0,01% | 4 882 NS | 31 de julio de 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 19 539 SH | 11 de septiembre de 2026 | Diario |
| DXUV · Dimensional ETF Trust | 0,00% | 371 NS | 31 de julio de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 7 996 NS | 31 de julio de 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 5 450 SH | 3 de septiembre de 2026 | Diario |
| DFUS · Dimensional ETF Trust | 0,00% | 975 NS | 31 de julio de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 1 127 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 111 919 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 364 413 SH | 19 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1 713 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1 002 SH | 19 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,00% | 25 446 SH | 19 de agosto de 2026 | Diario |
| IWN · iShares Trust | · | 77 593 SH | 11 de septiembre de 2026 | Diario |
TECX Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 16 analistas
COMPRA
Objetivo mediano
$78.00
+246,1%
6 37,5%
Compra fuerte
9 56,2%
Compra
1 6,2%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
8 analistas · 2026-10-03Objetivo medio $76.62 +240,0%
← Por Debajo de Todos los Objetivos
Precio Actual $22.54
Mín$60.00
Media$76.62
Máx$93.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| TECX | $391M | -5.2 | · | · | -27.7% | · |
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | · |
| OVID | $212M | -4.0 | 1181.3% | -240.1% | -18.7% | · |
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | · |
| DMAC | $428M | · | · | · | -78.7% | · |
| MYGN | $575M | -1.6 | -1.6% | -44.4% | -96.8% | 69.9% |
| SPRY | $1.16B | -6.7 | -5.5% | -203.3% | -111.8% | · |
| EDIT | $201M | -1.1 | 25.4% | -395.0% | -688.8% | · |
| EIKN | · | · | · | · | · | · |
| RCEL | $105M | -2.0 | 11.5% | -67.8% | 328.9% | 82.1% |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 6, 2026